Skip to main content

Hepatosplenic T-Cell Lymphoma

  • Living reference work entry
  • First Online:
Encyclopedia of Pathology

Part of the book series: Encyclopedia of Pathology ((EP))

  • 131 Accesses

Synonyms

REAL: hepatosplenic γδ T-cell lymphoma

Definition

Hepatosplenic T-cell lymphoma (HSTL) is an aggressive subtype of extranodal lymphoma characterized by a clinical presentation with splenomegaly commonly associated with hepatomegaly but without lymphadenopathy and a poor outcome. The neoplasm results from a proliferation of cytotoxic T-cells most often expressing the γδ T-cell receptor (TCR), or less often the αβ TCR. It is usually composed of monomorphic medium-sized lymphoid cells, with marked sinusoidal infiltration of spleen, liver, and bone marrow. It is associated with a recurrent isochromosome 7q cytogenetic abnormality, has a distinct molecular signature, and displays frequent mutations in genes of the JAK-STAT pathway (especially STAT5B) and in the SETD2 gene, encoding a histone methyltransferase.

Up to 20% of HSTL arise in the setting of chronic immune suppression, most commonly long term immunosuppressive therapy for solid organ transplantation or inflammatory bowel...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References and Further Reading

  • D’Amore, F., Gaulard, P., Trumper, L., Corradini, P., Kim, W. S., Specht, L., Bjerregaard Pedersen, L., Ladetto, M., & ESMO Guidelines Committee. (2015). Peripheral T-cell lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 26(Suppl 5), v108–v115.

    Article  Google Scholar 

  • Gaulard, P. Hepatosplenic T-cell lymphoma. In E. S. Jaffe, N. Lee Harris, D. A. Arber, E. Campo, N. L. Harris, & L. Quintanilla-Martinez (Eds.). (2016). Hematopathology (2nd ed., pp. 631–639). Elsevier.

    Google Scholar 

  • Lemonnier, F., Gaulard, P., & de Leval, L. (2018). New insights in the pathogenesis of T-cell lymphomas. Current Opinion in Oncology, 30(5), 277–284.

    PubMed  Google Scholar 

  • McKinney, M., Moffitt, A. B., Gaulard, P., Travert, M., De Leval, L., Nicolae, A., et al. (2017). The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discovery, 7(4), 369–379.

    Article  CAS  Google Scholar 

  • Swerdlow, S., Campo, E., Harris, N. L., Jaffe, E. S., Pileri, S. A., Stein, H., & Thiele, J. (Eds.). (2017). WHO classification of tumours of haematopoietic and lymphoid tissues (IARC WHO classification of Tumours) (Rev. 4th ed.). Lyon: IARC.

    Google Scholar 

  • Yabe, M., Miranda, R. N., & Medeiros, L. J. (2018). Hepatosplenic T-cell lymphoma: A review of clinicopathologic features, pathogenesis, and prognostic factors. Human Pathology, 74, 5–16.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Gaulard .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Gaulard, P., Lemonnier, F. (2019). Hepatosplenic T-Cell Lymphoma. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_3882-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-28845-1_3882-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-28845-1

  • Online ISBN: 978-3-319-28845-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics